No Data
SSY Group's Allopurinol Gains Approval for Market Release
SSY GROUP (02005.HK): Allopurinol has been approved for registration by the National Medical Products Administration to be used as an Active Pharmaceutical Ingredient in marketed formulations.
On April 28, Glonghui reported that SSY GROUP (02005.HK) announced that the group’s Allopurinol has been approved by China's National Medical Products Administration for registration as an Active Pharmaceutical Ingredient used in marketed formulations. Allopurinol is mainly used for the treatment of gout and hyperuricemia.
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.
① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?
SSY Group Expands Pharmaceutical Portfolio With New Approvals
SSY GROUP (02005.HK): Obtained the Pharmaceutical production registration approval for Dapagliflozin Metformin Extended-Release Tablets (Ⅰ) (Dapagliflozin 10mg and Metformin Hydrochloride 1000mg) and Arginine Ibuprofen Granules (0.4g and 0.2g).
On April 22, Gelonghui reported that SSY GROUP (02005.HK) has obtained the drug production registration approval from the National Medical Products Administration of China for Dapagliflozin Metformin Sustained Release Tablets (I) (Dapagliflozin 10mg and Metformin Hydrochloride 1000mg) and Arginine Ibuprofen Granules (0.4g and 0.2g), both classified as Chemical Drugs Class 4, considered to have passed consistency evaluation. Dapagliflozin Metformin Sustained Release Tablets (I) are mainly used to improve blood sugar control in adult patients with type 2 diabetes, while Arginine Ibuprofen Granules are mainly used for the following symptoms: toothache, dysmenorrhea, pain caused by injury.
Earnings Are Growing at SSY Group (HKG:2005) but Shareholders Still Don't Like Its Prospects
